Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
106-120 of 2113 results
UCLA, Bristol-Myers Squibb join hands for immuno-oncology research
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and the University of California, Los Angeles (UCLA) have signed a collaboration agreement as part of immuno-oncology rare population malignancy (I-O RPM) research program in the US.
Contract Research & Services > Contract Research > News
AstraZeneca collaborates with Wallenberg Centre for Protein Research
AstraZeneca and its global biologics research and development arm, MedImmune, have formed a three-year collaboration with the newly established Wallenberg Centre for Protein Research (WCPR).
Contract Research & Services > Contract Research > News
BMS establishes Center for Molecular Synthesis in collaboration with Princeton University
Bristol-Myers Squibb (BMS) and the Department of Chemistry at Princeton University today announced a new research collaboration, which includes the establishment of the Center for Molecular Synthesis (BMS-CMS).
Contract Research & Services > Contract Research > News
Amgen, Merck collaborate for two cancer immunotherapy trials
By PBR Staff Writer
Amgen and Merck have collaborated to evaluate a class of drugs that use the body’s immune system to fight cancer.
Contract Research & Services > Contract Research > News
Morphotek, Wisconsin university to study immunosuppressive effects of CA125 tumor antigen
Morphotek, a subsidiary of Eisai, has entered into a collaborative research agreement with University of Wisconsin-Madison (UW-Madison) to elucidate the immunosuppressive effects of the CA125 tumor antigen on the investigational monoclonal antibody farletuzumab.
Contract Research & Services > Contract Research > News
Zymeworks, GSK sign antibody collaboration deal
By PBR Staff Writer
Zymeworks has signed a collaboration and license agreement with GlaxoSmithKline (GSK) to develop and commercialize new Fc-engineered monoclonal and bi-specific antibody therapeutics.
Contract Research & Services > Contract Research > News
US researchers re-engineer CRISPR-Cas9 system to minimize gene editing errors
Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have re-engineered the CRISPR-Cas9 genome system to minimize gene editing errors.
Contract Research & Services > Contract Research > News
Children’s cancer death rates drop by 24% in last decade
The rate of children dying from cancer has dropped by 24% in the last decade, according to new figures published by Cancer Research UK.
Contract Research & Services > Contract Research > News
Brickell Biotech secures rights to ROR gamma inhibitors for psoriasis
By PBR Staff Writer
Brickell Biotech has secured the exclusive global rights to a series of novel retinoic acid–related orphan nuclear receptor gamma (RORγ) inhibitors from Orca Pharmaceuticals and New York University.
Contract Research & Services > Contract Research > News
LSP, Bristol-Myers Squibb partner to work on immuno-oncology innovation in Europe
By PBR Staff Writer
Life Sciences Partners (LSP) and Bristol-Myers Squibb have collaborated to find out European breakthrough technologies and products in immuno-oncology and other areas.
Contract Research & Services > Contract Research > News
Lilly, Merck extend immuno-oncology collaboration
Eli Lilly and Company and Merck have extended their immuno-oncology collaboration with Phase III nonsquamous non-small cell lung cancer trial (NSCLC).
Contract Research & Services > Contract Research > News
Servier exercises option to buy rights to Cellectis' UCART19 immunotherapy candidate
By PBR Staff Writer
Servier has exercised its option with Cellectis to acquire exclusive worldwide rights to UCART19, a TALEN gene-edited allogeneic chimeric antigen receptor T-cell (CAR-T) immunotherapy.
Contract Research & Services > Contract Research > News
Teva, University College London start brain imaging study to treat neurodegenerative diseases
By PBR Staff Writer
Teva Pharmaceutical Industries and University College London (UCL) have started a brain-imaging study to uncover a new approach in neurodegenerative disease.
Contract Research & Services > Contract Research > News
Ipsen, Interprotein partner to develop new therapeutic peptides in endocrinology
By PBR Staff Writer
Ipsen and Interprotein have partnered to develop and commercialize new therapeutic peptides in endocrinology.
Contract Research & Services > Contract Research > News
Turing Pharmaceuticals inks research deal with University of Toledo for canavan disease
Turing Pharmaceuticals has signed a sponsored research agreement with the University of Toledo to discover and develop new treatments for Canavan Disease.
Contract Research & Services > Contract Research > News
106-120 of 2113 results